Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02583815 · ClinicalTrials.gov registry record
Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 32
- Enrollment target
NCT02583815: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT02583815 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02583815 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
This is an open label feasibility pilot study of commercially available physical activity monitoring devices in patients receiving systemic therapy at the Harold Simmons Cancer Center, UT Southwestern Medical Center.
Primary Outcome
The primary endpoint of the study is the feasibility defined by subjects who use a PAM device for more than 42 of 84 days in the observation period (12 weeks +/- 14 days)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-09-15 |
What the finished NCT02583815 record still lists
NCT02583815 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02583815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02583815 about?
NCT02583815 is a clinical study titled "Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)". This is an open label feasibility pilot study of commercially available physical activity monitoring devices in patients receiving systemic therapy at the Harold Simmons Cancer Center, UT Southwestern Medical Center.
What is the current status of trial NCT02583815?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2015-08. Estimated completion is 2017-09-15.
Who is sponsoring clinical trial NCT02583815?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia